Terms: = Pancreatic cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Staging
4 results:
1. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract] [Full Text] [Related]
2. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract] [Full Text] [Related]
3. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/erk in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
4. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract] [Full Text] [Related]
